Cargando…
Discovery of a novel splice variant of Fcar (CD89) unravels sequence segments necessary for efficient secretion: A story of bad signal peptides and good ones that nevertheless do not make it
The IgA receptor, Fcar (CD89) consists of 5 sequence segments: 2 segments (S1, S2) forming the potential signal peptide, 2 extracellular EC domains that include the IgA binding site, and the transmembrane and cytoplasmic tail (TM/C) region. Numerous Fcar splice variants have been reported with vario...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351921/ https://www.ncbi.nlm.nih.gov/pubmed/28103138 http://dx.doi.org/10.1080/15384101.2017.1281480 |
_version_ | 1782514844508880896 |
---|---|
author | Lua, Wai-Heng Ling, Wei-Li Su, Chinh Tran-To Yeo, Joshua Yi Verma, Chandra Shekhar Eisenhaber, Birgit Eisenhaber, Frank Gan, Samuel Ken-En |
author_facet | Lua, Wai-Heng Ling, Wei-Li Su, Chinh Tran-To Yeo, Joshua Yi Verma, Chandra Shekhar Eisenhaber, Birgit Eisenhaber, Frank Gan, Samuel Ken-En |
author_sort | Lua, Wai-Heng |
collection | PubMed |
description | The IgA receptor, Fcar (CD89) consists of 5 sequence segments: 2 segments (S1, S2) forming the potential signal peptide, 2 extracellular EC domains that include the IgA binding site, and the transmembrane and cytoplasmic tail (TM/C) region. Numerous Fcar splice variants have been reported with various combinations of the sequence segments mentioned above. Here, we report a novel splice variant termed variant APD isolated from a healthy volunteer that lacks only the IgA-binding EC1 domain. Despite possessing the complete signal peptide S1+S2, the variant APD is only found in the intracellular space whereas the wild-type variant 1 is efficiently secreted and variant 4 leaks to the extracellular space. Further mutational experiments involving signal peptide replacements, cleavage site modifications, and studies on alternative isoforms demonstrate that despite the completeness of the signal peptide motif, the presence of the EC1 domain is essential for efficient extracellular export. |
format | Online Article Text |
id | pubmed-5351921 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-53519212017-03-24 Discovery of a novel splice variant of Fcar (CD89) unravels sequence segments necessary for efficient secretion: A story of bad signal peptides and good ones that nevertheless do not make it Lua, Wai-Heng Ling, Wei-Li Su, Chinh Tran-To Yeo, Joshua Yi Verma, Chandra Shekhar Eisenhaber, Birgit Eisenhaber, Frank Gan, Samuel Ken-En Cell Cycle Reports The IgA receptor, Fcar (CD89) consists of 5 sequence segments: 2 segments (S1, S2) forming the potential signal peptide, 2 extracellular EC domains that include the IgA binding site, and the transmembrane and cytoplasmic tail (TM/C) region. Numerous Fcar splice variants have been reported with various combinations of the sequence segments mentioned above. Here, we report a novel splice variant termed variant APD isolated from a healthy volunteer that lacks only the IgA-binding EC1 domain. Despite possessing the complete signal peptide S1+S2, the variant APD is only found in the intracellular space whereas the wild-type variant 1 is efficiently secreted and variant 4 leaks to the extracellular space. Further mutational experiments involving signal peptide replacements, cleavage site modifications, and studies on alternative isoforms demonstrate that despite the completeness of the signal peptide motif, the presence of the EC1 domain is essential for efficient extracellular export. Taylor & Francis 2017-01-19 /pmc/articles/PMC5351921/ /pubmed/28103138 http://dx.doi.org/10.1080/15384101.2017.1281480 Text en © 2017 The Author(s). Published with license by Taylor & Francis http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. |
spellingShingle | Reports Lua, Wai-Heng Ling, Wei-Li Su, Chinh Tran-To Yeo, Joshua Yi Verma, Chandra Shekhar Eisenhaber, Birgit Eisenhaber, Frank Gan, Samuel Ken-En Discovery of a novel splice variant of Fcar (CD89) unravels sequence segments necessary for efficient secretion: A story of bad signal peptides and good ones that nevertheless do not make it |
title | Discovery of a novel splice variant of Fcar (CD89) unravels sequence segments necessary for efficient secretion: A story of bad signal peptides and good ones that nevertheless do not make it |
title_full | Discovery of a novel splice variant of Fcar (CD89) unravels sequence segments necessary for efficient secretion: A story of bad signal peptides and good ones that nevertheless do not make it |
title_fullStr | Discovery of a novel splice variant of Fcar (CD89) unravels sequence segments necessary for efficient secretion: A story of bad signal peptides and good ones that nevertheless do not make it |
title_full_unstemmed | Discovery of a novel splice variant of Fcar (CD89) unravels sequence segments necessary for efficient secretion: A story of bad signal peptides and good ones that nevertheless do not make it |
title_short | Discovery of a novel splice variant of Fcar (CD89) unravels sequence segments necessary for efficient secretion: A story of bad signal peptides and good ones that nevertheless do not make it |
title_sort | discovery of a novel splice variant of fcar (cd89) unravels sequence segments necessary for efficient secretion: a story of bad signal peptides and good ones that nevertheless do not make it |
topic | Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351921/ https://www.ncbi.nlm.nih.gov/pubmed/28103138 http://dx.doi.org/10.1080/15384101.2017.1281480 |
work_keys_str_mv | AT luawaiheng discoveryofanovelsplicevariantoffcarcd89unravelssequencesegmentsnecessaryforefficientsecretionastoryofbadsignalpeptidesandgoodonesthatneverthelessdonotmakeit AT lingweili discoveryofanovelsplicevariantoffcarcd89unravelssequencesegmentsnecessaryforefficientsecretionastoryofbadsignalpeptidesandgoodonesthatneverthelessdonotmakeit AT suchinhtranto discoveryofanovelsplicevariantoffcarcd89unravelssequencesegmentsnecessaryforefficientsecretionastoryofbadsignalpeptidesandgoodonesthatneverthelessdonotmakeit AT yeojoshuayi discoveryofanovelsplicevariantoffcarcd89unravelssequencesegmentsnecessaryforefficientsecretionastoryofbadsignalpeptidesandgoodonesthatneverthelessdonotmakeit AT vermachandrashekhar discoveryofanovelsplicevariantoffcarcd89unravelssequencesegmentsnecessaryforefficientsecretionastoryofbadsignalpeptidesandgoodonesthatneverthelessdonotmakeit AT eisenhaberbirgit discoveryofanovelsplicevariantoffcarcd89unravelssequencesegmentsnecessaryforefficientsecretionastoryofbadsignalpeptidesandgoodonesthatneverthelessdonotmakeit AT eisenhaberfrank discoveryofanovelsplicevariantoffcarcd89unravelssequencesegmentsnecessaryforefficientsecretionastoryofbadsignalpeptidesandgoodonesthatneverthelessdonotmakeit AT gansamuelkenen discoveryofanovelsplicevariantoffcarcd89unravelssequencesegmentsnecessaryforefficientsecretionastoryofbadsignalpeptidesandgoodonesthatneverthelessdonotmakeit |